10 April 2015 | Tekcapital
Tekcapital acquires exclusive licence to a new technology for the non-invasive measurement of glucose in breath
Abstract: Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, is pleased to announce that it has acquired the exclusive license to a patent-pending technology for the measurement of glucose in breath from Purdue University. The technology addresses the need for a safe, fast, accurate and non- invasive method for health professionals to analyse samples of glucose in exhaled breath and adds to Tekcapital’s portfolio of patents for the non-invasive measurement of glucose which also includes a technology to test for glucose in saliva.
Contact:
(UK) Chris Lane, FTI Consulting LLP: Tel. +44 (0) 207 269 7276
About Tekcapital – The World’s Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties.
With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.
www.tekcapital.com
